| NAFLD | non-alcoholic fatty liver disease |
| NAFL | non-alcoholic fatty liver |
| NASH | non-alcoholic steato-hepatitis |
| T2DM | type-2 diabetes mellitus |
| GI | gastro-intestinal |
| TJ | tight-junctions |
| kDa | kiloDalton |
| TEER | transepithelial electric resistance |
| EVOM | epithelial volt/ohm meter |
| FABP | fatty acid binding protein |
| i-FABP | intestinal FABP |
| CHB | chronic hepatitis B |
| CHC | chronic hepatitis C |
| LPS | lipopolysaccharide |
| PAMPs | pathogen-associated molecular patterns |
| DAMPs | damage-associated molecular patterns |
| TFG-β | transforming growth factor-beta |
| IL-1 | interleukin-1 |
| IL-6 | interleukin-6 |
| TNF-α | tumour necrosis factor-alpha |
| TLR-4 | toll-like receptor 4 |
| GLP-2 | glucagon-like peptide 2 |
| GLUT-2 | glucose transporter-2 |
| BMI | body mass index |
| IL-1β | interleukin-1 beta |
| SCFA | short chain fatty acid |
| FMT | faecal microbiota transplant |